These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23587615)

  • 1. [The blood donors' haemovigilance in France].
    Ounnoughene N; Sandid I; Carlier M; Joussemet M; Ferry N
    Transfus Clin Biol; 2013 May; 20(2):182-92. PubMed ID: 23587615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Delayed adverse reactions to blood donation: From haemovigilance data to specific studies].
    Py JY; Durieux S; Barnoux M; Sapey T
    Transfus Clin Biol; 2016 Nov; 23(4):233-239. PubMed ID: 27769684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood donors--Serious adverse reactions (SAR) 2010-2014 EFS Châteauroux, France.
    Riga A; Sapey T; Bacanu M; Py JY; Dehaut F
    Transfus Clin Biol; 2015 Jun; 22(2):62-5. PubMed ID: 25997383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood donor haemovigilance in Yaoundé, Cameroon.
    Nchinda EC; Tagny CT; Mbanya D
    Transfus Med; 2012 Aug; 22(4):257-61. PubMed ID: 22630141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of blood donation reported to haemovigilance systems: analysis of eleven years of international surveillance.
    Wiersum-Osselton JC; Politis C; Richardson C; Goto N; Grouzi E; Marano G; Land KJ
    Vox Sang; 2021 Jul; 116(6):628-636. PubMed ID: 33278040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Haemovigilance donors: methods and results].
    Rebibo D; Danic B
    Transfus Clin Biol; 2007 May; 14(1):142-6. PubMed ID: 17513158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eight years with haemovigilance in Norway. What have we learnt?
    Steinsvåg CT; Espinosa A; Flesland Ø
    Transfus Apher Sci; 2013 Dec; 49(3):548-52. PubMed ID: 24157220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The French haemovigilance system.
    Debeir J; Noel L; Aullen J; Frette C; Sari F; Mai MP; Cosson A
    Vox Sang; 1999; 77(2):77-81. PubMed ID: 10516551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The French Haemovigilance System: organization and results for 2003.
    Rebibo D; Hauser L; Slimani A; Hervé P; Andreu G
    Transfus Apher Sci; 2004 Oct; 31(2):145-53. PubMed ID: 15501418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [European regulation on blood and blood components].
    Sandid I
    Transfus Clin Biol; 2010 Dec; 17(5-6):310-4. PubMed ID: 21050786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-time whole blood donation: A critical step for donor safety and retention on first three donations.
    Gillet P; Rapaille A; Benoît A; Ceinos M; Bertrand O; de Bouyalsky I; Govaerts B; Lambermont M
    Transfus Clin Biol; 2015; 22(5-6):312-7. PubMed ID: 26476508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serious adverse effects of blood collection].
    Danic B; Lefort C
    Transfus Clin Biol; 2010 Dec; 17(5-6):301-5. PubMed ID: 21051270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International bench marking of severe complications related to blood donation.
    Sorensen B; Jorgensen J
    Vox Sang; 2010 Oct; 99(3):294. PubMed ID: 20546205
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemovigilance: an effective tool for improving transfusion practice.
    de Vries RR; Faber JC; Strengers PF;
    Vox Sang; 2011 Jan; 100(1):60-7. PubMed ID: 21175656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Seventeen years of haemovigilance in France: assessment and outlook].
    Carlier M; Vo Mai MP; Fauveau L; Ounnoughene N; Sandid I; Renaudier P
    Transfus Clin Biol; 2011 Apr; 18(2):140-50. PubMed ID: 21474356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for complications in donors at first and repeat whole blood donation: a cohort study with assessment of the impact on donor return.
    Wiersum-Osselton JC; Marijt-van der Kreek T; Brand A; Veldhuizen I; van der Bom JG; de Kort W
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s28-36. PubMed ID: 23867173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incidents of blood donation].
    Danic B; Gouézec H; Bigant E; Thomas T
    Transfus Clin Biol; 2005 Jun; 12(2):153-9. PubMed ID: 15894504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor vigilance data of a blood transfusion service: A multicenter analysis.
    Burkhardt T; Dimanski B; Karl R; Sievert U; Karl A; Hübler C; Tonn T; Sopvinik I; Ertl H; Moog R
    Transfus Apher Sci; 2015 Oct; 53(2):180-4. PubMed ID: 26074050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality validation of data in national haemovigilance systems in Europe: report of a survey on current state of practice.
    Wiersum-Osselton JC; Faber JC; Politis C; Brand A; van der Bom JG; Schipperus MR
    Vox Sang; 2013 Apr; 104(3):214-7. PubMed ID: 23061879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasovagal reactions in whole blood and apheresis donors: a cross-sectional study on donor haemovigilance data from 2016 to 2019 in Italy.
    Piccinini V; Marano G; Catalano L; Pati I; Veropalumbo E; de Waure C; Pupella S; De Angelis V
    Blood Transfus; 2022 Jul; 20(4):281-291. PubMed ID: 34694220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.